Monsanto Roundup Trial Tracker
Anticipation is building around the belief that there could soon be an announcement of at least a partial settlement of U.S. lawsuits pitting thousands of U.S. cancer patients against Monsanto Co. over allegations the company hid the health risks of its Roundup herbicides. Investors in Bayer AG, the German company that bought Monsanto in 2018, are keeping a close eye on the status of three trials currently still on the docket to get underway this month.